Cambridge Cognition Expects ‘Significant’ Revenue From New Contract

Cambridge Cognition was recently awarded a major pharmaceutical clinical trial contract from Innovate UK, as well as a digital health catalyst grand. Collectively, the two are expected to bring about £2.3 million in revenue for the company.

The multi-nation phase four clinical study—which was initially expected to occur during the last quarter of 2017—will take place with an unnamed leading pharmaceutical company, and is projected to make a significant impact on the company’s revenues in 2018 and 2019. The company will be using the Innovate UK grant to help fund a new program that will . . .